Levetiracetam is a drug used to treat epilepsy. It is used for partial seizures, myoclonus or tonic - clonic seizures.

The global Levetiracetam market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Levetiracetam volume and value at global level, regional level and company level. From a global perspective, this report represents overall Levetiracetam market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Levetiracetam in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Levetiracetam manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
ABA Chem
Afton
SVK Laboratories Private Limited
Jubilant Pharma
Phalanx
Ogene
Anuh Pharma Ltd
Amoli
Tetrahedron

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Purity:98%
Purity:>98%

Segment by Application
Myoclonic Treatment
Tonic-clonic Seizures Treatment